William Abramovits MD
Acne & Rosacea, Cosmetic Dermatology, Dermatologic Surgery, Pediatric Dermatology
Owner, Investigator - DERMATOLOGY TREATMENT & RESEARCH CENTER
Join to View Full Profile
5310 Harvest Hill Rd#160Dallas, TX 75230
Phone+1 972-661-2729
Dr. Abramovits is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Dermatology, 1977 - 1979- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1976 - 1977
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1974 - 1975- University of Texas Health Science Center at HoustonInternship, Transitional Year, 1973 - 1974
Central University of VenezuelaClass of 1972
Certifications & Licensure
TX State Medical License 1989 - 2025
OK State Medical License 1976 - 1990
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 1 citationsAmzeeq (minocycline foam 4%) for topical treatment of acne vulgaris.Aditya K. Gupta, Anthony Bruce, Kimberly Dawn Vincent, William Abramovits
Skinmed. 2020-12-01 - 1 citationsEnstilar® (Calcipotriene and Betamethasone Dipropionate) Foam for Plaque Psoriasis in Adolescents Aged 12-17 Years.William Abramovits, Joyce M.C. Teng, Kimberly Dawn Vincent, Aditya K. Gupta
Skinmed. 2020-08-01 - AKLIEF (Trifarotene 0.005% [50 μg/g] Cream) for Topical Treatment of Acne VulgarisAditya K. Gupta, Anthony Bruce, William Abramovits, Kimberly Dawn Vincent
Skinmed. 2020-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
